A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.
Fuentes RE, Zaitsev S, Ahn HS, Hayes V, Kowalska MA, Lambert MP, Wang Y, Siegel DL, Bougie DW, Aster RH, Myers DD, Stepanova V, Cines DB, Muzykantov VR, Poncz M.
Fuentes RE, et al.
J Clin Invest. 2016 Feb;126(2):483-94. doi: 10.1172/JCI81470.
J Clin Invest. 2016.
PMID: 26690701
Free PMC article.